Safety, effectiveness and immunogenicity of heterologous mRNA-1273 boost after prime with Ad26.COV2.S among healthcare workers in South Africa: The single-arm, open-label, phase 3 SHERPA study
- the SHERPA study team
Research output: Contribution to journal › Article › peer-review
4
Citations
(Scopus)